BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

601 related articles for article (PubMed ID: 22049990)

  • 1. Antifungal susceptibility patterns of yeasts and filamentous fungi isolated from nail infection.
    Ataides FS; Chaul MH; El Essal FE; Costa CR; Souza LK; Fernandes OF; Silva MR
    J Eur Acad Dermatol Venereol; 2012 Dec; 26(12):1479-85. PubMed ID: 22049990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of fluconazole, itraconazole, voriconazole and terbinafine against fungi causing onychomycosis.
    Bueno JG; Martinez C; Zapata B; Sanclemente G; Gallego M; Mesa AC
    Clin Exp Dermatol; 2010 Aug; 35(6):658-63. PubMed ID: 19874354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and antifungal susceptibility of fungi isolated from dermatomycoses.
    Silva LB; de Oliveira DB; da Silva BV; de Souza RA; da Silva PR; Ferreira-Paim K; Andrade-Silva LE; Silva-Vergara ML; Andrade AA
    J Eur Acad Dermatol Venereol; 2014 May; 28(5):633-40. PubMed ID: 23556501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro antifungal susceptibility patterns of dermatophyte strains causing tinea unguium.
    Sarifakioglu E; Seçkin D; Demirbilek M; Can F
    Clin Exp Dermatol; 2007 Nov; 32(6):675-9. PubMed ID: 17714532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Onychomycosis-causing yeasts in four Mexican dermatology centers and their antifungal susceptibility to azolic compounds].
    Manzano-Gayosso P; Méndez-Tovar LJ; Arenas R; Hernández-Hernández F; Millán-Chiu B; Torres-Rodríguez JM; Cortés-González E; Fernández R; López-Martínez R
    Rev Iberoam Micol; 2011; 28(1):32-5. PubMed ID: 21147249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Onychomycosis in Adana, Turkey: a 5-year study.
    Ilkit M
    Int J Dermatol; 2005 Oct; 44(10):851-4. PubMed ID: 16207188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Onychomycosis in children: a survey of 46 cases.
    Romano C; Papini M; Ghilardi A; Gianni C
    Mycoses; 2005 Nov; 48(6):430-7. PubMed ID: 16262881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the antimicrobial susceptibility of fungi responsible for onychomycosis in Spain.
    Zalacain A; Obrador C; Martinez JP; Viñas M; Vinuesa T
    Med Mycol; 2011 Jul; 49(5):495-9. PubMed ID: 21142899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fusarium spp. as agents of onychomycosis in immunocompetent hosts.
    Guilhermetti E; Takahachi G; Shinobu CS; Svidzinski TI
    Int J Dermatol; 2007 Aug; 46(8):822-6. PubMed ID: 17651164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of voriconazole against dermatophytes, Scopulariopsis brevicaulis and other opportunistic fungi as agents of onychomycosis.
    Carrillo-Muñoz AJ; Giusiano G; Guarro J; Quindós G; Guardia C; del Valle O; Rodríguez V; Estivill D; Cárdenes CD
    Int J Antimicrob Agents; 2007 Aug; 30(2):157-61. PubMed ID: 17555945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Causative agents of onychomycosis--a retrospective study].
    Mügge C; Haustein UF; Nenoff P
    J Dtsch Dermatol Ges; 2006 Mar; 4(3):218-28. PubMed ID: 16626318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiologic and clinicomycologic profile of onychomycosis from north India.
    Sarma S; Capoor MR; Deb M; Ramesh V; Aggarwal P
    Int J Dermatol; 2008 Jun; 47(6):584-7. PubMed ID: 18477149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antifungal susceptibilities and genetic relatedness of serial Trichophyton rubrum isolates from patients with onychomycosis of the toenail.
    Bradley MC; Leidich S; Isham N; Elewski BE; Ghannoum MA
    Mycoses; 1999; 42 Suppl 2():105-10. PubMed ID: 10865915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro susceptibility of dermatomycoses agents to six antifungal drugs and evaluation by fractional inhibitory concentration index of combined effects of amorolfine and itraconazole in dermatophytes.
    Tamura T; Asahara M; Yamamoto M; Yamaura M; Matsumura M; Goto K; Rezaei-Matehkolaei A; Mirhendi H; Makimura M; Makimura K
    Microbiol Immunol; 2014 Jan; 58(1):1-8. PubMed ID: 24215461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Yeasts as important agents of onychomycosis: in vitro activity of propolis against yeasts isolated from patients with nail infection.
    Khosravi AR; Shokri H; Nikaein D; Mansouri P; Erfanmanesh A; Chalangari R; Katalin M
    J Altern Complement Med; 2013 Jan; 19(1):57-62. PubMed ID: 22954465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Onychomycosis in Tehran, Iran: prevailing fungi and treatment with itraconazole.
    Khosravi AR; Mansouri P
    Mycopathologia; 2001; 150(1):9-13. PubMed ID: 11392568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genotyping and In Vitro Antifungal Susceptibility Testing of Fusarium Isolates from Onychomycosis in India.
    Gupta C; Jongman M; Das S; Snehaa K; Bhattacharya SN; Seyedmousavi S; van Diepeningen AD
    Mycopathologia; 2016 Aug; 181(7-8):497-504. PubMed ID: 27138574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. White superficial onychomycosis of the fingernail caused by Trichophyton rubrum in an immunocompetent patient.
    Kornbleuth S; Hsu S
    Cutis; 1999 Aug; 64(2):99-100. PubMed ID: 10467501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro susceptibility testing of amorolfine in pathogenic fungi isolated from dermatomycosis patients in China.
    Li RY; Wan Z; Wang AP; Shen YN; Lu CM; Li M; Xi LY; Liu WD; Zeng FQ
    Mycoses; 2004 Oct; 47(9-10):402-6. PubMed ID: 15504124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fungi causing onychomycoses in The Netherlands].
    Staats CC; Korstanje MJ
    Ned Tijdschr Geneeskd; 1994 Nov; 138(47):2340-3. PubMed ID: 7969633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.